How Well Osimertinib Works to Control EGFR-Positive Lung Cancer – ECOG-ACRIN Cancer Research Group

ECOG-ACRIN Cancer Research Group shared a post on X:

“The PrE1702 Real World Data research study is evaluating how well osimertinib with or without chemotherapy works to control EGFR-positive Lung Cancer in patients not participating in a clinical trial.